• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macros
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macros
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
Nairametrics
No Result
View All Result
Home Markets Fixed Income Securities
Is Neimeth Pharamaceuticals Plc Share Price Popping Already?

Is Neimeth Pharamaceuticals Plc Share Price Popping Already?

Nairametrics by Nairametrics
10 years ago
in Securities, Spotlight, Stock Market
Share on FacebookShare on TwitterShare on Linkedin

Screenshot (68)

Neimeth Pharmaceuticals Plc released its audited results on Jan 31 showing a profit of N130million compared to the N40million loss it posted a year earlier. Revenue also rose 30% and adjusted operational profit 659%. It was indeed a great result for the company and not surprisingly it is now being rewarded heftily by the market.

Prior to when the results was announced, Neimeth was trading for N1.57. At the close of trading today it closed at N2.27 a 44.5% increase in a span of 7 days (57.6% YTD)!! Is this reward justified? Well only a proper valuation of their shares will tell in my opinion. However, gleaning from the market data, Nemeth currently trades at 22.7x P.E ratio and a Price to book ratio of 1.6x. By most standards that is an expensive stock despite this recent results. And I haven’t heard any news yet that suggest the company was unto something big.

Nevertheless it’s the market and at this rate I won’t be surprised if the stock gains 100% in the next month. Neimeth is not in our portfolio and we have no plans of buying it at the moment.

Tags: News Review
Nairametrics

Nairametrics

Nairametrics is Nigeria's top business news and financial analysis website. We focus on providing resources that help small businesses and retail investors make better investing decisions. Nairametrics is updated daily by a team of professionals. Post updated as "Nairametrics" are published by our Editorial Board.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *







NM newsletters
HFM
Glo
Kwakol
Abbey
Zenth Bank
UBA
Mega Millions

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • Wike seeks NASS approval to spend N61.6 billion on priority projects  
  • Tinubu to unveil corporate governance code for public institutions in Q1 2024—FRC  
  • Naira bounces back, rises to N831.47/$1 at the official market   

Follow us on social media:

Recent News

Wike reduces C-of-O fee for FCT from N5 million to N3.5 million

Wike seeks NASS approval to spend N61.6 billion on priority projects  

November 29, 2023
infrastructure gaps,

Tinubu to unveil corporate governance code for public institutions in Q1 2024—FRC  

November 29, 2023
  • Download Nairametrics iOS App
  • Download Nairametrics Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macros
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
  • Login
  • Sign Up

© 2023 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In